The macromolecular aggregate as a drug carrier

Cellular and Molecular Biology Letters

Volumn 5, Issue 4, 2000, Pages 433-440

  Langner, Marek ^a   Ugorski, Maciej ^b,c  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Liposomes; Macromolecular Aggregates; Targeted Drug Delivery

Indexed keywords

DRUG CARRIER; PACLITAXEL;

ARTICLE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG POTENCY; DRUG SOLUBILITY; MACROMOLECULE;

EID: 0034534105     PISSN: 14258153     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Strategies towards predicting peptide cellular permeability from computed molecular descriptors
2. Absorption prediction from physicochemical parameters
3. On the mechanism of DNA transfection: Efficient gene transfer without viruses
4. Nonviral strategies for gene therapy
5. Liposomes as vehicles for the presentation of a synthetic peptide containing an epitope of hepatitis A virus
6. Liposomal drug formulations. Rationale for development and what we can expect for the future
7. Lipids, liposomes, rational drug design
8. Novel applications of liposomes
9. Targeted drug delivery
10. Liposomes in drug delivery: Progress and limitations
11. Toxicological profile and pharmacokinetics of a unilamellar liposomal vesicle formulation of amphotericin B (AmBiosome) in rats
12. Lipid microspheres (lipid emulsions) as a drug carrier - An overview
13. Ocular drug targeting by liposomes and their corneal interactions
14. The interaction of liposomes with the complement system
15. Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions
16. Liposomes coated with chemically modified dextran interact with human endothelial cells
17. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue
18. Delivery of gamma-imaging agents by liposomes
19. Long-circulating liposomes
20. Stealth liposomes for the targeting of drug in cancer therapy
21. Sterically stabilized doxorubicin loaded liposomes (DOX-SL): From basic to the clinic
22. Immunoliposomes for cancer treatment
23. A novel influenza subjunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II Induction of TH1 and TH2 responses in mice
24. AmBiosome (liposomal Amphotericin B): A comparative review
25. Stealth liposomes: From theory to product